Aastrom Biosciences Inc
ASTM
Log in to follow and get free email alerts when insiders file.
Sector
Biological Products, Except Diagnostic Substances
Industry
Drugs
Recent Filings - SEC Insider Transactions (Form 3,4,5)
File Date | Date | Company | Filer | Security | Shares | Price | $ Total | % Change | 10% | Dir. | Off. | Code | View | SEC | SIC | SIC Group | SIC Division |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buy / Sell (dollars)
1 Month
20.6%79.4%
$289,500.00
avg. $289,500.00
$1.12M
avg. $1.12M
Buy/Sell Ratio
0.259
Transactions
16
Filers
8
3 Month
24.4%75.6%
$565,600.00
avg. $565,600.00
$1.76M
avg. $585,365.91
Buy/Sell Ratio
0.322
Transactions
22
Filers
9
12 Month
20.4%79.6%
$2.36M
avg. $2.36M
$9.24M
avg. $769,682.57
Buy/Sell Ratio
0.256
Transactions
58
Filers
23
24 Month
20.9%79.1%
$3.13M
avg. $3.13M
$11.83M
avg. $493,037.95
Buy/Sell Ratio
0.265
Transactions
93
Filers
47
Filers
CIK | Name | Title | Last Transaction | First Transaction | Director | Officer | 10% Own. | Other |
---|---|---|---|---|---|---|---|---|
1626325 | Hopper Jonathan Mark | Chief Medical Officer | 2022-03-03 | 2020-12-23 | ||||
1313403 | Colangelo Dominick | President and CEO | 2022-02-22 | 2020-02-18 | ||||
1841148 | Mara Joseph Anthony Jr | Chief Financial Officer | 2022-02-22 | 2021-01-26 | ||||
1801993 | Flynn Sean C. | VP, General Counsel | 2022-02-22 | 2021-02-22 | ||||
1778858 | Halpin Michael | Chief Operating Officer | 2022-02-08 | 2020-06-18 | ||||
1379970 | GILMAN STEVEN C | 2021-12-01 | 2020-05-01 | |||||
1300997 | Wotton Paul K | 2021-05-17 | 2020-05-01 | |||||
1340228 | Rubino Alan L | 2021-03-22 | 2020-05-01 | |||||
1220363 | ZERBE ROBERT L MD | 2020-11-24 | 2020-05-01 | |||||
1585084 | Hagen Heidi | 2020-05-01 | 2020-05-01 | |||||
1214938 | MCLAUGHLIN KEVIN F | 2020-05-01 | 2020-05-01 | |||||